Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study

Annals of Neurology

Volumn 77, Issue 5, 2015, Pages 877-883

  Alonso, Alvaro ^a   Huang, Xuemei ^b   Mosley, Thomas H ^c   Heiss, Gerardo ^d   Chen, Honglei ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARASYMPATHETIC TONE; PARKINSON DISEASE; PRIORITY JOURNAL; QRS COMPLEX; RISK FACTOR; SYMPATHETIC TONE; BRADYCARDIA; COHORT ANALYSIS; DEMOGRAPHY; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

ATHEROSCLEROSIS; BRADYCARDIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84928139635     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24393     Document Type: Article

References (22)

1. Chaudhuri KR, Schapira AHV,. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009; 8: 464-474.
2. Jain S, Goldstein DS,. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Neurobiol Dis 2012; 46: 572-580.
3. Amino T, Orimo S, Itoh Y, et al. Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 2005; 15: 29-34.
4. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999; 52: 1269-1271.
5. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
6. Tolosa E, Gaig C, Santamaria J, Compta Y,. Diagnosis and the premotor phase of Parkinson disease. Neurology 2009; 72: S12-S20.
7. Jain S, Ton TG, Perera S, et al. Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic study. Mov Disord 2012; 27: 988-995.
8. ARIC Investigators,. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
9. Liao D, Barnes RW, Chambless LE, Heiss G,. A computer algorithm to impute interrupted heart rate data for the spectral analysis of heart rate variability-the ARIC study. Comput Biomed Res 1996; 29: 140-151.
10. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
11. Akselrod S, Gordon D, Ubel FA, et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-222.
12. Lombardi F, Malliani A, Pagani M, Cerutti S,. Heart rate variability and its sympatho-vagal modulation. Cardiovasc Res 1996; 32: 208-216.
13. Dekker JM, Crow RS, Folsom AR, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Circulation 2000; 102: 1239-1244.
14. Liao D, Carnethon M, Evans GW, et al. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes 2002; 51: 3524-3531.
15. Schroeder EB, Liao D, Chambless LE, et al. Hypertension, blood pressure, and heart rate variability. The Atherosclerosis Risk in Communities (ARIC) Study. Hypertension 2003; 42: 1106-1111.
16. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51-65.
17. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
18. Haapaniemi TH, Pursiainen V, Korpelainen JT, et al. Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70: 305-310.
19. Sauvageot N, Vaillant M, Diederich NJ,. Reduced sympathetically driven heart rate variability during sleep in Parkinson's disease: a case-control polysomnography-based study. Mov Disord 2011; 26: 234-240.
20. Trachani E, Constantoyannis C, Sakellaropoulos GC, et al. Heart rate variability in Parkinson's disease unaffected by deep brain stimulation. Acta Neurol Scand 2012; 126: 56-61.
21. Maetzler W, Karam M, Berger MF, et al. Time- and frequency-domain parameters of heart rate variability and sympathetic skin response in Parkinson's disease. J Neural Transm 2015; 122: 419-425.
22. Orimo S, Uchihara T, Nakamura A, et al. Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131: 642-650.